483 Document: Institute of Regenerative and Cellular Medicine, Oct 19, 2021

FDANews 483 Institute of Regenerative and Cellular Medicine Oct 19 2021 top
Christina D. Mello FDA Investigator Ronda R. Loyd Jones FDA Investigator Loyd Jones, Ronda R FDA Investigator

On Oct 19, 2021, the FDA inspected Institute of Regenerative and Cellular Medicine's Santa Monica site. Explore the inspectional observations.